Detalhe da pesquisa
1.
Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL.
Blood
; 139(12): 1794-1806, 2022 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699592
2.
Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study.
Lancet Oncol
; 23(8): 1066-1077, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839786
3.
Efficient CRISPR/Cas9 Disruption of Autoimmune-Associated Genes Reveals Key Signaling Programs in Primary Human T Cells.
J Immunol
; 203(12): 3166-3178, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722988
4.
Circulating integrin alpha4/beta7+ lymphocytes targeted by vedolizumab have a pro-inflammatory phenotype.
Clin Immunol
; 193: 24-32, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29842945
5.
Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation state.
Clin Immunol
; 181: 67-74, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28645874
6.
Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes.
Cell Immunol
; 319: 3-9, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844471
7.
Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk alleles.
Front Immunol
; 15: 1383110, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650930
8.
A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI).
Cytometry A
; 83(8): 728-38, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23788464
9.
Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel.
Mol Cancer Ther
; 22(3): 406-418, 2023 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36595660
10.
Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes.
Sci Immunol
; 1(5)2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664195
11.
Avidity-dependent programming of autoreactive T cells in T1D.
PLoS One
; 9(5): e98074, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24844227